Ondine Biomedical Inc. (AIM:OBI)
14.89
+0.14 (0.95%)
Jun 16, 2026, 10:31 AM GMT
Ondine Biomedical Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 10.57 | 9.77 | 2.98 | 13.13 | 30.37 |
Cash & Short-Term Investments | 10.57 | 9.77 | 2.98 | 13.13 | 30.37 |
Cash Growth | 8.18% | 227.64% | -77.29% | -56.78% | 4750.64% |
Accounts Receivable | 0.41 | 0.46 | 0.32 | 0.13 | 0.16 |
Other Receivables | 0.05 | 0.06 | 0 | 0.05 | 0.09 |
Receivables | 0.46 | 0.51 | 0.33 | 0.18 | 0.25 |
Inventory | 1.82 | 1.27 | 1.07 | 1.29 | 1.06 |
Prepaid Expenses | 0.41 | 0.48 | 0.22 | 0.38 | 1.83 |
Restricted Cash | - | 0.16 | 0.16 | 0.15 | - |
Other Current Assets | 0.01 | - | - | - | - |
Total Current Assets | 13.26 | 12.19 | 4.75 | 15.13 | 33.5 |
Property, Plant & Equipment | 1.07 | 0.6 | 0.95 | 1.4 | 0.6 |
Other Long-Term Assets | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 |
Total Assets | 14.38 | 12.82 | 5.73 | 16.57 | 34.14 |
Accounts Payable | 1.04 | 1.59 | 1.36 | 0.39 | 1.2 |
Accrued Expenses | 9.31 | 4.19 | 1.75 | 3.16 | 2.08 |
Current Portion of Leases | 0.31 | 0.17 | 0.38 | 0.36 | 0.15 |
Other Current Liabilities | 0.14 | - | - | - | 0.5 |
Total Current Liabilities | 10.8 | 5.95 | 3.49 | 3.91 | 3.92 |
Long-Term Debt | - | - | - | 0.48 | 0.47 |
Long-Term Leases | 0.1 | - | 0.16 | 0.54 | 0.09 |
Total Liabilities | 10.9 | 5.95 | 3.65 | 4.93 | 4.48 |
Common Stock | 288.19 | 262.6 | 239.65 | 235.04 | 235.04 |
Additional Paid-In Capital | 10.53 | 10.53 | 10.53 | 10.53 | 10.53 |
Retained Earnings | -314.95 | -285.43 | -266.33 | -251.92 | -232.54 |
Comprehensive Income & Other | 19.71 | 19.18 | 18.24 | 18 | 16.64 |
Total Common Equity | 3.49 | 6.88 | 2.09 | 11.64 | 29.66 |
Shareholders' Equity | 3.49 | 6.88 | 2.09 | 11.64 | 29.66 |
Total Liabilities & Equity | 14.38 | 12.82 | 5.73 | 16.57 | 34.14 |
Total Debt | 0.41 | 0.17 | 0.54 | 1.38 | 0.71 |
Net Cash (Debt) | 10.15 | 9.6 | 2.44 | 11.75 | 29.66 |
Net Cash Growth | 5.77% | 293.40% | -79.23% | -60.39% | - |
Net Cash Per Share | 0.02 | 0.03 | 0.01 | 0.06 | 0.37 |
Filing Date Shares Outstanding | 518.37 | 404 | 226.75 | 194.59 | 194.58 |
Total Common Shares Outstanding | 518.37 | 404 | 226.75 | 194.59 | 194.58 |
Working Capital | 2.47 | 6.24 | 1.26 | 11.22 | 29.58 |
Book Value Per Share | 0.01 | 0.02 | 0.01 | 0.06 | 0.15 |
Tangible Book Value | 3.49 | 6.88 | 2.09 | 11.64 | 29.66 |
Tangible Book Value Per Share | 0.01 | 0.02 | 0.01 | 0.06 | 0.15 |
Machinery | 1.62 | 1.21 | 0.99 | 1.95 | 1.77 |
Leasehold Improvements | 0.3 | 0.33 | 0.31 | 0.29 | 0.28 |